IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

MISTRETTA, FRANCESCO ALESSANDRO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 9.375
AS - Asia 7.810
NA - Nord America 7.041
SA - Sud America 735
AF - Africa 211
OC - Oceania 55
Continente sconosciuto - Info sul continente non disponibili 5
Totale 25.232
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.729
DE - Germania 4.454
SG - Singapore 2.216
CN - Cina 2.176
IT - Italia 1.698
BD - Bangladesh 1.142
HK - Hong Kong 795
GB - Regno Unito 787
SE - Svezia 676
BR - Brasile 558
RU - Federazione Russa 514
VN - Vietnam 509
FR - Francia 343
IN - India 301
CA - Canada 187
IE - Irlanda 167
NL - Olanda 167
FI - Finlandia 118
JP - Giappone 118
ID - Indonesia 101
CI - Costa d'Avorio 99
KR - Corea 97
DK - Danimarca 93
TR - Turchia 74
PH - Filippine 61
MX - Messico 56
AR - Argentina 55
ES - Italia 53
AU - Australia 50
UA - Ucraina 49
PL - Polonia 42
BE - Belgio 36
AT - Austria 35
CH - Svizzera 35
IQ - Iraq 35
EC - Ecuador 25
CO - Colombia 24
MA - Marocco 24
ZA - Sudafrica 24
PE - Perù 23
EG - Egitto 17
RO - Romania 17
CL - Cile 16
AE - Emirati Arabi Uniti 15
MY - Malesia 15
PK - Pakistan 15
SA - Arabia Saudita 15
VE - Venezuela 15
CZ - Repubblica Ceca 14
IR - Iran 13
TN - Tunisia 13
PT - Portogallo 12
UZ - Uzbekistan 12
CR - Costa Rica 11
NP - Nepal 11
TT - Trinidad e Tobago 11
TW - Taiwan 11
IL - Israele 10
KE - Kenya 10
AZ - Azerbaigian 9
JO - Giordania 9
PY - Paraguay 9
JM - Giamaica 8
KG - Kirghizistan 8
NG - Nigeria 8
TH - Thailandia 8
AL - Albania 7
RS - Serbia 7
BO - Bolivia 6
HN - Honduras 6
KZ - Kazakistan 6
LU - Lussemburgo 6
EE - Estonia 5
LT - Lituania 5
OM - Oman 5
SK - Slovacchia (Repubblica Slovacca) 5
GR - Grecia 4
GT - Guatemala 4
HU - Ungheria 4
NZ - Nuova Zelanda 4
PA - Panama 4
PS - Palestinian Territory 4
SV - El Salvador 4
UY - Uruguay 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AM - Armenia 3
AO - Angola 3
BG - Bulgaria 3
BH - Bahrain 3
BY - Bielorussia 3
CU - Cuba 3
DO - Repubblica Dominicana 3
DZ - Algeria 3
ET - Etiopia 3
HR - Croazia 3
LA - Repubblica Popolare Democratica del Laos 3
LB - Libano 3
MK - Macedonia 3
NI - Nicaragua 3
NO - Norvegia 3
Totale 25.196
Salva come PNG Salva come JPEG
Città #
Frankfurt am Main 4.151
Singapore 1.146
Ashburn 999
Dallas 900
Hong Kong 614
Southend 579
San Jose 537
Milan 503
Chandler 481
Beijing 334
Santa Clara 278
New York 251
Council Bluffs 229
Los Angeles 218
Hefei 200
Dublin 161
Princeton 158
Buffalo 152
Lauterbourg 151
Ho Chi Minh City 144
Fairfield 128
Rome 124
Wilmington 111
Guangzhou 107
Hanoi 106
Moscow 104
Abidjan 99
Ann Arbor 99
Bengaluru 95
Seattle 92
Houston 88
Tokyo 78
Jakarta 74
Seoul 72
Shanghai 72
Boardman 71
Helsinki 71
Dearborn 70
Munich 67
Naples 67
Phoenix 65
Columbus 62
Des Moines 61
Cambridge 58
São Paulo 57
Toronto 55
Montreal 51
Turin 51
Istanbul 49
Woodbridge 47
Nanjing 46
Tianjin 45
Berlin 43
Jinan 41
Cangzhou 40
Chicago 35
Hyderabad 34
Brussels 33
Shenzhen 32
The Dalles 32
Changsha 31
London 31
Nuremberg 29
Orem 29
Florence 28
Shenyang 28
Amsterdam 25
Palermo 24
Bari 23
Turku 23
Wuhan 23
Atlanta 22
Warsaw 22
Sydney 21
Catania 20
Dong Ket 20
Brooklyn 19
Düsseldorf 19
Mumbai 19
Redwood City 19
Zhengzhou 19
Central District 18
Charlotte 18
Da Nang 18
Haiphong 18
Lima 18
Rio de Janeiro 18
Lappeenranta 17
San Diego 17
Washington 17
Bologna 16
Fremont 16
Genoa 16
Hebei 16
Boston 15
Chongqing 15
Dhaka 15
San Francisco 14
Zurich 14
Cagliari 13
Totale 15.721
Salva come PNG Salva come JPEG
Nome #
A novel nomogram to identify candidates for active surveillance among patients with ISUP Grade Group 1 or ISUP Grade Group 2 prostate cancer, according to multiparametric magnetic resonance imaging findings 483
Radioablation +/- hormonotherapy for prostate cancer oligorecurrences (Radiosa trial): Potential of imaging and biology (AIRC IG-22159) 422
Advanced Age Impacts Survival After Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma 364
Repeated MRIs during Active Surveillance: natural history of prostatic lesions and upgrading rates 359
Accuracy of the European Association of Urology (EAU) NMIBC 2021 scoring model in predicting progression in a large cohort of HG T1 NMIBC patients treated with BCG 346
Multiparametric magnetic resonance imaging and frozen-section analysis efficiently predict upgrading, upstaging, and extraprostatic extension in patients undergoing nerve-sparing robotic-assisted radical prostatectomy 325
Survival Effect of Chemotherapy in Metastatic Upper Urinary Tract Urothelial Carcinoma 312
Phase II prospective trial “Give Me Five” short-term high precision radiotherapy for early prostate cancer with simultaneous boost to the dominant intraprostatic lesion : the impact of toxicity on quality of life (AIRC IG-13218) 311
Contemporary rates and predictors of open conversion during minimally invasive radical prostatectomy for non-metastatic prostate cancer 306
CyberKnife Ultra-Hypofractionated SBRT for Localized Prostate Cancer with Dose Escalation to the Dominant Intraprostatic Lesion: In Silico Planning Study 302
MRI-based radiomics signature for localized prostate cancer: a new clinical tool for cancer aggressiveness prediction? Sub-study of prospective phase II trial on ultra-hypofractionated radiotherapy (AIRC IG-13218) 300
Oligorecurrent Prostate Cancer and Stereotactic Body Radiotherapy: Where Are We Now? A Systematic Review and Meta-analysis of Prospective Studies 299
Increased Body Mass Index Is a Risk Factor for Poor Clinical Outcomes after Radical Prostatectomy in Men with International Society of Urological Pathology Grade Group 1 Prostate Cancer Diagnosed with Systematic Biopsies 299
High-performance prediction models for prostate cancer radiomics 298
Multiparametric Magnetic Resonance Imaging Second Opinion May Reduce the Number of Unnecessary Prostate Biopsies : Time to Improve Radiologists’ Training Program? 295
Metabolic syndrome predicts worse perioperative outcomes in patients treated with partial nephrectomy for renal cell carcinoma 273
Long-term follow‐up outcomes after percutaneous us/ct‐guided radiofrequency ablation for ct1a‐b renal masses : Experience from single high‐volume referral center 270
Correction: Confirmatory multiparametric magnetic resonance imaging at recruitment confers prolonged stay in active surveillance and decreases the rate of upgrading at follow-up (Prostate Cancer and Prostatic Diseases, (2020), 23, 1, (94-101), 10.1038/s41391-019-0160-3) 268
A comprehensive evaluation of sexual and reproductive outcomes following robot-assisted retroperitoneal lymph node dissection for nonseminomatous germ cell tumor 265
A novel nomogram predicting lymph node invasion among patients with prostate cancer: The importance of extracapsular extension at multiparametric magnetic resonance imaging 265
Exploring mirna signature and other potential biomarkers for oligometastatic prostate cancer characterization: The biological challenge behind clinical practice : a narrative review 257
Therapeutic Sequences in the Treatment of High-Risk Prostate Cancer: Paving the Way Towards Multimodal Tailored Approaches 257
Confirmatory multiparametric magnetic resonance imaging at recruitment confers prolonged stay in active surveillance and decreases the rate of upgrading at follow-up 251
Pathological findings at radical prostatectomy of biopsy naïve men diagnosed with MRI targeted biopsy alone without concomitant standard systematic sampling 251
Robot assisted radical prostatectomy in kidney transplant recipients: surgical, oncological and functional outcomes of two different robotic approaches 250
Neutrophil, platelets, and eosinophil to lymphocyte ratios predict gleason score upgrading in low-risk prostate cancer patients 250
Correlation between radiological and biological features and clinical outcomes in early prostate cancer: an exploratory subgroup analysis 245
Adjuvant radiotherapy in node positive prostate cancer patients: a debate still on. when, for whom? 244
Robot-assisted intracorporeal orthotopic ileal neobladder : Description of the “shell” technique 240
Multiparametric Magnetic-Resonance to Confirm Eligibility to an Active Surveillance Program for Low-Risk Prostate Cancer: Intermediate Time Results of a Third Referral High Volume Centre Active Surveillance Protocol 239
Posterior musculofascial reconstruction after radical prostatectomy: an updated systematic review and a meta-analysis 235
Quality assurance for automatically generated contours with additional deep learning 234
Penile-Sparing Surgery for Tumour Recurrence after Previous Glansectomy/Partial Penectomy: Treatment Feasibility and Oncological Outcomes 233
Dosimetric Evaluation of the Inter-Fraction Motion of Organs at Risk in SBRT for Nodal Oligometastatic Prostate Cancer 233
Predictors of residual T1 high grade on re-transurethral resection in a large multi-institutional cohort of patients with primary T1 high-grade/grade 3 bladder cancer 233
Survival Effect of Nephroureterectomy in Metastatic Upper Urinary Tract Urothelial Carcinoma 230
Predicting Peri-Operative Outcomes in Patients Treated with Percutaneous Thermal Ablation for Small Renal Masses: The SuNS Nephrometry Score 226
Clinical evaluation and disease management of PI-RADS 3 lesions. Analysis from a single tertiary high-volume center 225
ADT with SBRT versus SBRT alone for hormone-sensitive oligorecurrent prostate cancer (RADIOSA): a randomised, open-label, phase 2 clinical trial 223
Artificial intelligence and radiomics in evaluation of kidney lesions: a comprehensive literature review 219
Thulium–yttrium–aluminium–garnet (Tm:YAG) laser treatment of penile cancer: oncological results, functional outcomes, and quality of life 218
Survival effect of perioperative systemic chemotherapy on overall mortality in locally advanced and/or positive regional lymph node non-metastatic urothelial carcinoma of the upper urinary tract 215
MRI-targeted or systematic random biopsies for prostate cancer diagnosis in biopsy naïve patients: follow-up of a PRECISION trial-like retrospective cohort 214
Comparison of perioperative outcomes between open and minimally invasive nephroureterectomy : a population-based analysis 212
Artificial Intelligence in the Advanced Diagnosis of Bladder Cancer-Comprehensive Literature Review and Future Advancement 209
Sexual function recovery after robot-assisted radical prostatectomy : outcomes from an Italian referral centre and predicting nomogram 209
Safety and feasibility of thullium laser transurethral resection of prostate for the treatment of benign prostatic enlargement in overweight patients 209
Nephroureterectomy with or without Bladder Cuff Excision for Localized Urothelial Carcinoma of the Renal Pelvis 208
Adherence to guideline recommendations for lymph node dissection in squamous cell carcinoma of the penis : effect on survival and complication rates 207
Association of statin use and oncological outcomes in patients with first diagnosis of T1 high grade non-muscle invasive urothelial bladder cancer: results from a multicentre study 206
Robot-Assisted Radical Cystectomy for Nonmetastatic Urothelial Carcinoma of Urinary Bladder: A Comparison between Intracorporeal Versus Extracorporeal Orthotopic Ileal Neobladder 202
Three vs. Four Cycles of Neoadjuvant Chemotherapy for Localized Muscle Invasive Bladder Cancer Undergoing Radical Cystectomy: A Retrospective Multi-Institutional Analysis 201
Assessment of the VENUSS and GRANT Models for Individual Prediction of Cancer-specific Survival in Surgically Treated Nonmetastatic Papillary Renal Cell Carcinoma 199
Partial Cystectomy With Pelvic Lymph Node Dissection for Patients With Nonmetastatic Stage pT2-T3 Urothelial Carcinoma of Urinary Bladder: Temporal Trends and Survival Outcomes 193
Contemporary trends of pelvic lymph node dissection at radical cystectomy for urothelial carcinoma of urinary bladder and associated cancer specific mortality and complications : comparison between octogenarian versus younger patients 192
Oligo metastatic renal cell carcinoma : stereotactic body radiation therapy, if, when and how? 191
Modified Glasgow Prognostic Score as a Predictor of Recurrence in Patients with High Grade Non-Muscle Invasive Bladder Cancer Undergoing Intravesical Bacillus Calmette-Guerin Immunotherapy 188
Conditional survival of patients with stage I-III squamous cell carcinoma of the penis: temporal changes in cancer-specific mortality 188
Insertion of a testicular prosthesis at the time of radical orchiectomy for testicular cancer is safe in patients who will subsequently undergo chemotherapy or radiotherapy 188
Thermal ablation for small renal masses: Identifying the most appropriate tumor size cut-off for predicting perioperative and oncological outcomes 188
Oligometastatic Prostate Cancer: A Comparison between Multimodality Treatment vs. Androgen Deprivation Therapy Alone 187
Penile-sparing surgery for patients with superficial or initially invasive squamous cell carcinoma of the penis : long-term oncological outcomes 187
Comparison of Mexican-American vs Caucasian prostate cancer active surveillance candidates 183
Post-resection: hemostatis, checking for rectal injury and anastomic leaks 182
Predictive clinico-pathological factors to identify BCG, unresponsive patients, after re-resection for T1 high grade non-muscle invasive bladder cancer 182
Impact of Age on Outcomes of Patients With Pure Carcinoma In Situ of the Bladder: Multi-Institutional Cohort Analysis 181
Impact of the COVID-19 pandemic on urological cancers: The surgical experience of two cancer hubs in London and Milan 181
A guide for oncologic patient management during covid-19 pandemic: The initial experience of an Italian oncologic hub with exemplificative focus on uro-oncologic patients 181
Contemporary conditional cancer-specific survival after radical nephroureterectomy in patients with nonmetastatic urothelial carcinoma of upper urinary tract 181
Association between previous negative biopsies and lower rates of progression during active surveillance for prostate cancer 179
Meta-analysis of studies comparing oncologic outcomes of radical prostatectomy and brachytherapy for localized prostate cancer 179
Can we predict pathology without surgery? Weighing the added value of multiparametric MRI and whole prostate radiomics in integrative machine learning models 178
A Phase 3 Prospective Randomized Trial to Evaluate the Impact of Augmented Reality During Robot-assisted Radical Prostatectomy on the Rates of Postoperativane Surgical Margins: A Clinical Trial Protocol 174
Incidence of fatigue and low-dose corticosteroid use in prostate cancer patients receiving systemic treatment: a meta-analysis of randomized controlled trials 174
Effect of stage and grade migration on cancer specific mortality in renal cell carcinoma patients, according to clear cell vs. non-clear cell histology: A contemporary population-based analysis 174
Radiomics in prostate cancer: an up-to-date review 174
What is the best time for postoperative radiation therapy in pN1 prostate cancer? 172
Association Between Systemic Therapy and/or Cytoreductive Nephrectomy and Survival in Contemporary Metastatic Non–clear Cell Renal Cell Carcinoma Patients 170
Conditional survival of patients with low-risk prostate cancer: Temporal changes in active surveillance permanence over time 169
Robot-assisted Partial Nephrectomy: 5-yr Oncological Outcomes at a Single European Tertiary Cancer Center 169
Contemporary North-American population-based validation of the International Germ Cell Consensus Classification for metastatic germ cell tumors of the testis 167
Uro-oncologic patient management during the COVID-19 pandemic: Survey findings from an Italian oncologic hub 164
Extended versus standard pelvic lymphadenectomy during robot-Assisted radical prostatectomy: The role of extended template as an independent predictor of lymph node invasion with comparable morbidity burden 162
Microwave vs radiofrequency ablation for small renal masses: perioperative and oncological outcomes 160
The Effect of Surgical Resection on Cancer-Specific Mortality in Pelvic Soft Tissue Sarcoma According to Histologic Subtype and Stage 157
Rates of lymph node invasion and their impact on cancer specific mortality in upper urinary tract urothelial carcinoma 153
Critical Appraisal of Leibovich 2018 and GRANT Models for Prediction of Cancer-Specific Survival in Non-Metastatic Chromophobe Renal Cell Carcinoma 151
Continuity of cancer care : The surgical experience of two large cancer hubs in London and Milan 150
Adherence to Guideline Recommendations for Perioperative Chemotherapy in Patients with pN2-3 M0 Squamous Cell Carcinoma of the Penis : Temporal Trends and Survival Outcomes 145
Thermal ablation for local tumor recurrence after previous partial nephrectomy: Perioperative and oncological outcomes 144
Thulium laser treatment of upper urinary tract carcinoma: A multi-institutional analysis of surgical and oncological outcomes 143
Long-term oncologic and functional outcomes after robot-assisted partial nephrectomy in elderly patients 142
Active surveillance for prostate cancer: comparison between incidental tumors vs. tumors diagnosed at prostate biopsies 142
Contemporary Assessment of Survival Rates in Stage I Testicular Seminoma : a Population-Based Comparison Between Surveillance and Active Treatment After Orchiectomy 141
In-hospital length of stay after major surgical oncological procedures 138
Limited versus extended pelvic lymphadenectomy during robot-assisted radical prostatectomy: impact on the number of nodes and on nodal invasion 137
Differences in life expectancy of adrenocortical carcinoma patients vs. age‑ and sex-matched population controls 136
Outcomes of robot-assisted simple enucleation of renal masses : a single European center experience 136
Evaluation of margins during radical prostatectomy: confocal microscopy vs frozen section analysis 136
Demographic and Clinical Characteristics of Malignant Solitary Fibrous Tumors: A SEER Database Analysis 135
Totale 21.670
Salva come PNG Salva come JPEG
Categoria #
all - tutte 67.627
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 67.627
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.321 52 75 56 59 171 108 50 85 125 108 109 323
2022/20231.890 240 208 144 157 146 301 100 141 240 26 142 45
2023/20243.993 70 88 101 111 340 165 625 518 265 489 604 617
2024/20255.103 586 601 501 487 274 207 190 363 216 364 417 897
2025/202611.120 974 784 1.501 881 741 526 1.090 451 868 686 1.556 1.062
2026/2027393 393 0 0 0 0 0 0 0 0 0 0 0
Totale 26.033